Catalent
CTLT
#1776
Rank
C$16.50 B
Marketcap
C$90.91
Share price
0.00%
Change (1 day)
16.04%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): C-$8.56

According to Catalent's latest financial reports the company's current EPS (TTM) is C-$9.06. In 2023 the company made an earnings per share (EPS) of C-$9.74 a decrease over its 2022 EPS that were of C$3.25.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$8.56-12.12%
2023C-$9.74-399.56%
2022C$3.25-30.58%
2021C$4.6879.67%
2020C$2.61114.12%
2019C$1.22-15%
2018C$1.4375.44%
2017C$0.82-22.97%
2016C$1.06-59.56%
2015C$2.62282.05%
2014C$0.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
C-$1.09-87.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$5.20-157.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
C-$1.07-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
C-$2.12-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA